- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04003077
Laser Meridian Massage in Heroin Addicts
Adjuvant Laser Meridian Massage in Heroin Addicts With Methadone Treatment: an Observational Case-controlled Study
Study Overview
Detailed Description
Objective: To investigate the effect of adjuvant laser meridian massage in heroin addicts with methadone treatment and establish the model of laser meridian massage treatment for drug addiction.
Methods: A case-controlled study is conducted. Fifteen male heroin addicts are enrolled from Addiction Treatment Center as treatment group. They are treated with laser meridian massage on the back including Bladder meridian and Governor vessel three times a week for 4 weeks. A control group of participants without laser meridian massage treatment are matched by age. Check urine morphine before, 2 and 4 weeks of treatment. Subjects report their times or days of heroin use and self-fill Visual Analogue Scales of heroin craving / refusal of heroin use (0-10 points) during last week before, 2 and 4 weeks of treatment. Subjects report their quality of life using Short Form-12v2 before and 4 weeks of treatment. Obtain the subject's pulse diagnosis and heart rate variability after a single treatment. Independent t test, Mann-Whitney U test, chi-square test and Fisher's exact test were used to compare the differences between the treatment and control groups. Repeated measures ANOVA, Generalized estimating equations, paired t test and Wilcoxon Signed-Rank test were used for comparison between the treatment and control groups.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 833
- Recruiting
- Kaohsiung Chang Gung Memorial Hospital
-
Contact:
- Wen-Long Hu, MD, MS
- Phone Number: 6255 +886-7-7317123
- Email: oolonghu@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Provide informed consent
- Male older than 20 years
- Diagnosed with opioid use disorder according to DSM-5 and received methadone treatment more than 1 month
Exclusion Criteria:
- Received Antidepressant or antipsychotic
- Received Chinese herb or acupuncture treatment during last 30 days
- Critical illness
- Did not meet the physician's assessment for recruitment
- Patients with Human immunodeficiency virus infection
- Did not provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Laser meridian massage
They are treated with laser meridian massage on the back including Bladder meridian and Governor vessel three times a week for 4 weeks.
|
The participants will undergo 12 sessions of laser meridian massage, thrice a week, for 4 weeks, using a gallium aluminum arsenide LaserPen (maximal power, 150 mW; wavelength, 810nm; area of probe, 0.5cm^2; power density, 300mW/cm^2; pulsed wave; RJ-Laser, Reimers & Janssen GmbH, Waldkirch, Germany).
The laser treatment will be applied to the back including Bladder meridian (BL11-25) and Governor vessel (GV3-14) for 15 minutes, to deliver a total treatment dose of 67.5J/cm^2.
|
NO_INTERVENTION: Control
A control group of participants without laser meridian massage treatment are matched by age.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heroin use
Time Frame: 2 weeks of treatment
|
Times or days of heroin use during last week
|
2 weeks of treatment
|
Heroin use
Time Frame: 4 weeks of treatment
|
Times or days of heroin use during last week
|
4 weeks of treatment
|
Urine morphine
Time Frame: 2 weeks of treatment
|
Obtainurinary morphine concentration
|
2 weeks of treatment
|
Urine morphine
Time Frame: 4 weeks of treatment
|
Obtain urinary morphine concentration
|
4 weeks of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heroin craving / refusal of heroin use
Time Frame: 2 weeks of treatment
|
Obtain Visual Analogue Scales (VAS) of heroin craving / refusal of heroin use (0-10 points) during last week.
VAS score 0 of heroin craving indicates no heroin craving, while VAS 10 indicates strongest heroin craving.
VAS 0 of refusal of heroin use indicates no refusal of heroin, while VAS 10 indicates absolute refusal of heroin.
|
2 weeks of treatment
|
Heroin craving / refusal of heroin use
Time Frame: 4 weeks of treatment
|
Obtain Visual Analogue Scales (VAS) of heroin craving / refusal of heroin use (0-10 points) during last week.
VAS score 0 of heroin craving indicates no heroin craving, while VAS 10 indicates strongest heroin craving.
VAS 0 of refusal of heroin use indicates no refusal of heroin, while VAS 10 indicates absolute refusal of heroin.
|
4 weeks of treatment
|
Short Form-12v2 Health Survey
Time Frame: 4 weeks of treatment
|
The SF-12v2® Health Survey (SF-12v2) is a multipurpose, short-form health survey with 12 questions that yields an eight-scale profile of functional health and well-being, as well as two psychometrically based physical and mental health summary measures and a preference-based health utility index. The PRO CoRE, part of the Smart Measurement® System suite of products and Optum's upgrade to the QualityMetric Health Outcomes™ Scoring Software, is used for scoring the SF-12v2® Health Survey. |
4 weeks of treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PMRPG8J0081
- M08G1056 (OTHER_GRANT: Ministry of Health and Welfare)
- 201801823A3 (OTHER: Chang Gung Medical Foundation Institutional Review Board)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heroin Dependence
-
National Health Research Institutes, TaiwanUnknown
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)Completed
-
National Health Research Institutes, TaiwanUnknown
-
Shanghai Mental Health CenterShanghai Center of Biomedicine DevelopmentCompleted
-
University of PittsburghIndiana University of PennsylvaniaCompletedSubstance Use Disorders | Benzodiazepine Dependence | Alcohol Use Disorder | Substance Abuse | Opioid-use Disorder | Cocaine Use Disorder | Alcohol Abuse | Opiate Dependence | Alcohol Withdrawal | Benzodiazepine Abuse | Cocaine Abuse | Heroin Abuse | Cocaine Withdrawal | Opiate Withdrawal Syndrome | Heroin Overdoses | Heroin...United States
-
Hurd,Yasmin, Ph.D.Jazz PharmaceuticalsRecruitingSubstance-Related Disorders | Opioid-Related Disorders | Opioid Use Disorder | Heroin AbuseUnited States
-
Icahn School of Medicine at Mount SinaiNational Center for Complementary and Integrative Health (NCCIH); University...RecruitingOpiate Use DisorderUnited States
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)Completed
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)Completed
Clinical Trials on laser meridian massage
-
Shahid Beheshti University of Medical SciencesUnknownKeratoconusIran, Islamic Republic of
-
Liao Jian AnRecruitingHead and Neck CancerTaiwan
-
Umm Al-Qura UniversityRecruitingLaser Therapy | Bell Palsy | Facial Paralyses, IdiopathicSaudi Arabia
-
The Affiliated Hospital of Qingdao UniversityEnrolling by invitation
-
HLT Inc.WithdrawnAortic RegurgitationUnited States
-
Kaohsiung Medical UniversityRecruiting
-
Universidad de ExtremaduraCompleted
-
Korea Health Industry Development InstituteRecruitingParkinson DiseaseKorea, Republic of
-
Chang Gung Memorial HospitalUnknown